Morgan Stanley’s BIND THERAPEUTICS INC BIND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q3 | – | Sell |
-1,166
| Closed | – | – | 6743 |
|
|
2016
Q2 | $0 | Sell |
1,166
-1,539
| -57% | -$1.26K | ﹤0.01% | 6976 |
|
|
2016
Q1 | $6K | Sell |
2,705
-600
| -18% | -$1.09K | ﹤0.01% | 6266 |
|
|
2015
Q4 | $8K | Sell |
3,305
-18,095
| -85% | -$73.1K | ﹤0.01% | 6304 |
|
|
2015
Q3 | $96K | Sell |
21,400
-4,033
| -16% | -$19.8K | ﹤0.01% | 5444 |
|
|
2015
Q2 | $142K | Buy |
25,433
+17,783
| +232% | +$110K | ﹤0.01% | 5408 |
|
|
2015
Q1 | $43K | Buy |
7,650
+4,740
| +163% | +$29.1K | ﹤0.01% | 5850 |
|
|
2014
Q4 | $16K | Buy |
2,910
+2,210
| +316% | +$16.6K | ﹤0.01% | 6118 |
|
|
2014
Q3 | $6K | Sell |
700
-887
| -56% | -$8.74K | ﹤0.01% | 6314 |
|
|
2014
Q2 | $21K | Sell |
1,587
-4,065
| -72% | -$39.8K | ﹤0.01% | 6024 |
|
|
2014
Q1 | $68K | Sell |
5,652
-3,530
| -38% | -$46.1K | ﹤0.01% | 5601 |
|
|
2013
Q4 | $138K | Buy |
+9,182
| New | +$117K | ﹤0.01% | 5215 |
|
Morgan Stanley's BIND Position: Q3 2016 in Review
Morgan Stanley sold out of BIND THERAPEUTICS INC (BIND) in Q3 2016, closing a stake of 1,166 shares.
Morgan Stanley first reported a position in BIND in Q4 2013 and held it in 11 quarters. The position peaked at $142K in Q2 2015. 0 funds tracked by Wall St. Rank hold BIND as of Q3 2016.
- Morgan Stanley reported no remaining BIND THERAPEUTICS INC position as of Q3 2016 after selling out during the quarter.
- Morgan Stanley sold 1,166 BIND THERAPEUTICS INC shares in Q3 2016.
- Morgan Stanley first reported a position in BIND THERAPEUTICS INC in Q4 2013 and held it in 11 quarters.
- Morgan Stanley's BIND THERAPEUTICS INC position peaked at $142K in Q2 2015.
- 0 funds tracked by Wall St. Rank held BIND THERAPEUTICS INC as of Q3 2016.
Based on Morgan Stanley's 13F filing for Q3 2016, filed 10 Nov 2016.